Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo-Reference-Cited by-同舟云学术

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo

Published:2020-04-02 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Di Francesco Luigia,Bruno Annalisa,Ricciotti Emanuela,Tacconelli Stefania,Dovizio Melania,Guillem-Llobat Paloma,Alisi Maria Alessandra,Garrone Beatrice,Coletta Isabella,Mangano Giorgina,Milanese Claudio,FitzGerald Garret A.,Patrignani Paola

Funder

Angelini Pharma

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference60 articles.

1. mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress;Avendaño;Hypertension,2018

2. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile;Boulet;J. Biol. Chem.,2004

3. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro;Bruno;Biochem. Pharmacol.,2010

4. Identification and development of mPGES-1 inhibitors: where we are at;Chang;Future Med. Chem.,2011

5. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway;Chen;Genes Dev.,1995

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio;Pharmacological Research;2022-08

2. Dissection of Anti-Inflammatory and Immunomodulatory Activity of Mangifera Indica L. Reveals the Modulation of COX-2/MPGES-1 Axis and Th17/Treg Ratio;SSRN Electronic Journal;2022

3. Trends in the enzymatic inhibition by natural extracts;Value-Addition in Food Products and Processing Through Enzyme Technology;2022

4. Engineering ‘Enzymelink’ for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity;Future Medicinal Chemistry;2021-07

5. Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition;Frontiers in Chemistry;2021-05-07